senetics InnovationAward 2021 for Cfm Oskar Tropitzsch GmbH
For years, senetics has promoted and supported the innovative capacity of institutes and companies in the medical technology, pharmaceutical and biotechnology industries.
The “senetics Innovation Award” for the most innovative product idea was presented in 2012 for the first time.
Under the patronage of the Bavarian State Ministry, the senetics expert jury gives the awards to innovative institutes and companies in various categories.
Most innovative product in the healthcare sector
Now we, the Cfm Oskar Tropitzsch GmbH, received the InnovationAward 2021 – in the category “Most innovative product in the healthcare sector”.
We are proud to receive this award for a product (OSW-1 / ZJ-1) of our Antibody-Drug-Conjugates.
Antibody-drug conjugates for cancer research
Antibody drug conjugates (ADCs) are a new approach in the development of innovative drugs for cancer therapy. The basic technology was researched by Paul Ehrlich in 1908 and awarded the Nobel Prize for Medicine.
Human antibodies are linked to highly potent toxins to specifically kill cancer cells and enable healing. The technology also reduces side effects.
Leading biotech and pharmaceutical companies trust us in the sustainable sourcing of toxins as payloads for ADCs – including substances with IC50 values in the picomolar range and special mechanisms of action (modes of action).
Thank you very much for this award.